Shawn He

Shawn He, PhD, is Chief Scientific Officer at JW Therapeutics. Prior to joining JW, he served as CSO at Cure Genetics, where he built a CAR-NKT pipeline for solid tumors. Previously, he was EVP of R&D at Celularity, leading development of novel allogeneic CAR-T and CAR-NK therapies. Earlier, Dr. He held roles of increasing responsibility at Celgene Cellular Therapeutics, advancing three cell therapy programs into IND-enabling studies, all of which entered the clinic across eight indications. He received his PhD from the University of Maryland, College Park.